Related references
Note: Only part of the references are listed.Engineering and Characterization of the Chimeric Antibody That Targets the C-terminal Telopeptide of the α2 Chain of Human Collagen I: A Next Step in the Quest to Reduce Localized Fibrosis
Jolanta Fertala et al.
CONNECTIVE TISSUE RESEARCH (2013)
Engineered antibody approaches for Alzheimer's disease immunotherapy
Remy Robert et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2012)
scFv Antibody: Principles and Clinical Application
Zuhaida Asra Ahmad et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Engineering antibodies for the 21st century
James S. Huston
PROTEIN ENGINEERING DESIGN & SELECTION (2012)
A combined strategy improves the solubility of aggregation-prone single-chain variable fragment antibodies
Wei Sun et al.
PROTEIN EXPRESSION AND PURIFICATION (2012)
Toward the estimation of the absolute quality of individual protein structure models
Pascal Benkert et al.
BIOINFORMATICS (2011)
Role of naturally occurring osmolytes in protein folding and stability
Raj Kumar
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2009)
Collagen fibril formation - A new target to limit fibrosis
Hye Jin Chung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Heterotrimeric type I collagen C-telopeptide conformation as docked to its helix receptor
JP Malone et al.
BIOCHEMISTRY (2004)
Share Paper
